COLLAGEN AND JOINT

Produit de santé naturel homologué au Canada

Titulaire: GFR Pharma Ltd.
NPN ou DIN-HM: 80120515
Statut: Licence active
Date de licence: 10 août 2022
Date de révision: 9 avril 2025
Forme: Poudre
Voie d'administration: Orale
Type de demande: Générale (non traditionelle)

Si ce produit était vendu en France

Aucun point relevé par les règles que nous appliquons.

Une quantité quotidienne est calculée uniquement pour une posologie adulte orale explicite, exprimée par jour et dans une unité solide correspondant à la forme du produit. Les unités ambiguës, liquides, poudres et doses pédiatriques ne sont pas extrapolées. Une quantité non calculée n'est pas comparée aux limites de dose. Cette analyse ne constitue pas une autorisation de vente en France ni une évaluation de sécurité ou d'efficacité.

Composition

Ingrédient médicinal et source	Par unité posologique, selon la source	Par jour au plus, adulte
Collagène hydrolysé Puissance : 167 mg L-Lysine	7 000 mg	Non calculée
Bromélaïne de tige Source : Ananas comosus var. comosus - Tige	486 000 FCC PU	Non calculée
Bromélaïne de tige Source : Ananas comosus var. comosus - Tige	13,5 mg	Non calculée
Membrane de coquille d'oeuf de poule partiellement hydrolysée Source : Gallus gallus - Coquille d'oeuf	500 mg	Non calculée

Ingrédients non médicinaux

Saveur de vanille, Extrait de feuilles de stévia

Doses recommandées au Canada

Population	Âge	Quantité par prise	Fréquence
Adultes	minimum : 18 ans	1 Portions	1 jour

Usages autorisés au Canada

Texte fourni en anglais, faute de texte français disponible.

A factor in maintaining healthy cartilage and/or joint health. Helps protect against the deterioration of cartilage and relieves joint pain associated with osteoarthritis. Helps to protect against the deterioration of cartilage. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Used in herbal medicine to help relieve minor pain, swelling and inflammation. Helps to reduce joint pain associated with osteoarthritis. Source of (the) essential amino acid(s) (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, valine) for the maintenance of good health (and involved in protein synthesis). Source of (the) non-essential amino acid(s) (alanine, arginine, aspartic acid, glutamic acid, glycine, proline, serine, tyrosine) involved in protein synthesis. Source of the essential amino acid lysine to help in collagen formation. Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise. Helps to minimize discomfort due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise. Starts to reduce joint pain due to moderate intensity aerobic exercise in as little/as quickly as 1 day and joint stiffness in as little/as quickly as 5 days. Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5-7 days). Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as the first day). Helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women. Helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. Helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women.

Un usage autorisé au Canada n'est pas une allégation de santé autorisée dans l'Union européenne. Consultez le registre des allégations de santé.